Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Profound Medical (PROF) Operating Expenses (2019 - 2026)

Profound Medical has reported Operating Expenses over the past 7 years, most recently at $11.4 million for Q4 2025.

  • For Q4 2025, Operating Expenses changed 0.47% year-over-year to $11.4 million; the TTM value through Dec 2025 reached $52.6 million, up 31.29%, while the annual FY2025 figure was $52.6 million, 31.29% up from the prior year.
  • Operating Expenses for Q4 2025 was $11.4 million at Profound Medical, down from $12.8 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $15.4 million in Q2 2025 and troughed at $6.8 million in Q1 2021.
  • A 5-year average of $9.7 million and a median of $9.3 million in 2022 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: skyrocketed 74.47% in 2021 and later dropped 18.28% in 2023.
  • Year by year, Operating Expenses stood at $10.2 million in 2021, then decreased by 8.25% to $9.4 million in 2022, then grew by 4.53% to $9.8 million in 2023, then rose by 15.31% to $11.3 million in 2024, then increased by 0.47% to $11.4 million in 2025.
  • Business Quant data shows Operating Expenses for PROF at $11.4 million in Q4 2025, $12.8 million in Q3 2025, and $15.4 million in Q2 2025.